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Abstract—In this paper we introduce a novel design for a 
translational medical research ecosystem. Translational medical 
research is an emerging field of work with the aim to bridge the 
gap between basic medical science research and clinical 
research/patient care.  We analyze the key challenges for digital 
ecosystems for translational research, based on real world 
scenarios posed by the Lab for Translational Research at the 
Harvard Medical School and the Genomics Research Centre of 
the Griffith University, and show how traditional IT approaches 
fail to fulfill these challenges. We then introduce our novel 
translational research ecosystem. Several key contributions are 
made: A novel approach to managing ad-hoc research ecosystems 
is introduced; a new security model for translational research is 
developed which allows each participating cite to retain control 
over it’s data and define it’s own policies to ensure legal and 
ethical compliance; a novel interactive access control framework 
allows users to easily share data while adhering to their 
organization’s policies.     
Digital Ecosystem; Translational Research; Mind Mesh; Access 
Control; Access Negotiation; Legal Compliance;  
I.  INTRODUCTION  
Translational medical research [1] is an emerging field of 
work with the aim to bridge the gap between basic medical 
science research (benchside) and clinical research/patient care 
(bedside). The main focus of the translational research 
paradigm is the more efficient translation of basic science 
research discoveries into clinical science/patient care (bench to 
bedside). The return route (bedside to bench) describes the 
translation process in which benchside researchers gain access 
to direct feedback, clinical data and impulses for new research. 
While the National Institute of Health (NIH) funds billions in 
basic science research, according to a study less than 10% of 
promising biomedical discoveries were established in clinical 
practice within 20 years [2]. Thus, the main motivation of the 
medical funding in this area is to improve the bench to bedside 
aspect of translational research. Accordingly, the NIH 
identified translational research as a vital part of their roadmap 
and endorsed the foundation of Clinical and Translational 
Science Awards (CTSAs) in 2005. These grants were created 
to stimulate progress from scientific innovation to health 
improvement and by 2012 will have an estimated annual 
budget of $500 million [3] [4]. The main target of this funding 
is creating methodologies and collaborations to improve bench 
to bedside translation and is focused on the human and 
organizational aspects of translational research, since it is these 
human aspects that have been identified as the main hindrance 
in the translational process [5]. In particular, the difficulties of 
bridging the different operational procedures of bench and 
bedside organizations and the often dynamic, trans-discipline, 
trans-organizational nature of collaborations are an important 
aspect of this problem. Interestingly, IT solutions which are 
used in support of translational medical research, such as [6] 
[7] [8], do not focus on this area but mainly focus on creating a 
centralized system for data integration, access and search in a 
particular problem domain. Thus, while they offer invaluable 
support to medical researchers within a single domain who 
have a clear translational path, they currently do not offer 
support for the entire spectrum of translational research [9]. We 
argue that one main reason for this shortcoming is the 
paradigm choice of the system, i.e. that centralized and focused 
IT infrastructure paradigms are used to realize the systems. 
This works well for certain highly organized areas of 
translational research, such as cancer research, but does not 
cope well with the more ad-hoc and dynamic requirements of 
general translational research, as we will demonstrate with the 
requirements from the Lab for Translational Research at the 
Harvard Medical School and the Genomics Research Centre of 
the Griffith University.  
In this paper, we argue that a digital ecosystem paradigm 
better suits translational research needs and present a novel 
design for a transnational, translational research ecosystem to 
facilitate ad-hoc bench to bedside and bedside to bench 
research collaborations. Several key contributions are made – 
we identify why traditional approaches to IT infrastructures fall 
short of fulfilling the needs of translational researchers and 
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deduce the key issues which a digital ecosystem based 
approach must fulfill; we present a novel decentralized support 
infrastructure for the management of translational research 
efforts which suits the ad-hoc nature of many research efforts 
better than current non-ecosystem approaches; we present a 
new flexible security model which can adapt to the different 
security requirements of bench and bedside research 
environments and in keeping with the digital ecosystem 
paradigm, each participating organization retains control over 
the security mechanisms and policies guarding their data and 
meta-data.  
II. SCENARIO 
In the following two example scenarios of translational 
research collaborations are sketched.  
A. Bedside to Bench 
There are two scenarios of main interest in the bedside to 
bench route: The validation of research hypotheses based on 
clinical trials/experience and conducting clinical trials during 
benchside research. The gathering of existing clinical data or 
locating suitable candidates for a clinical trial are the issues to 
be dealt with here. Both cases involve the sharing of bedside 
data with benchside researchers. Currently, bedside data is 
mainly shared manually. In the following two example cases 
are presented: 
Trial support: If a bench side researcher knows of clinical 
data of relevance to her work, she needs to apply for ethical 
approval from the benchside organization to request the data 
from the bedside researcher. A committee grants this ethical 
approval on a case-by-case basis. Once approval is granted the 
data can be requested manually, i.e. a letter requesting the data 
is sent. The bedside researcher must then apply for and get 
ethical approval from the bedside organization. This also needs 
to be approved by a committee on a case-by-case basis. When 
the final ethical approval is granted, the bedside researcher 
must manually prepare the data for the translational sharing 
process (e.g. anonymization, pseudonymization) and deliver it 
to the benchside researcher (usually through print-outs or 
DVDs). This process typically takes around one year. 
Hypothesis Control: A link between endothelial progenitor 
cells in the bone marrow (BM-EPCs) and tumor 
vascularization was discovered. In-vitro research showed that 
inhibiting these BM-EPCs could impact tumor growth. Thus, 
drugs were invented to inhibit these. However, in clinical 
studies it was discovered that the impact on tumor growth was 
much smaller than expected and not sufficient to combat the 
growth of cancer. Thus, the hypothesis that BM-EPCs could be 
used to inhibit cancer growth needed to be revisited by the 
bench side researcher.  
B. Bench to Bedside 
Due to the failure of the BM-EPCs to inhibit cancer growth 
to the degree expected, new bench side research into EPCs was 
undertaken. A new local source of endothelial progenitor cells 
in the vascular zone (VZ) around blood vessels was discovered 
and studied by the co-authors. These new findings show that 
these VW-EPCs are recruited for tumor vascularization to the 
degree that was missing in the BM-EPC results. This 
groundbreaking discovery has obvious applications in cancer 
treatment, however there are also a number of other areas of 
medicine such as atherosclerosis, wound healing and 
recovering ischaemic tissue after heart attacks that could 
benefit from this discovery. These basic science findings now 
need to be translated into medically applicable results. 
Therefore, drugs need to be researched to inhibit or stimulate 
the VW-EPCs in the different areas of application. For this, 
experts from the fields of oncology, dermatology and 
cardiology need to involved in the respective drug research and 
clinical studies.  
Currently benchside research results are usually disseminated 
manually through for instance publications, conference 
presentations or direct discussions between colleagues. There is 
very little in terms of IT infrastructure to facilitate this, 
particularly across multiple domains.  
III. PROBLEM STATEMENT 
Both aforementioned scenarios require a digital ecosystem 
that links researchers across several organizations and domains. 
The digital ecosystem infrastructure must also handle data with 
and without identifying patient information. Thus, multiple 
organizational, legal and ethical as well as security and privacy 
related problems arise. While bedside organizations are often 
centrally organized and have security, privacy and ethical 
policies, which are also centrally defined (though often not 
centrally enforced), benchside research is often a more self-
organized and ad-hoc environment in which individual 
researchers can have far more control over security and privacy 
policies than in a clinical environment. Thus, a digital 
ecosystem that incorporates both worlds needs to deal with the 
following challenges beyond what traditional translational 
research systems offer. 
A. Legal/Security 
One of the main issues hindering the adoption of IT 
solutions in the medical sector is security. Regan et al. studied 
the security issues in a clinical ecosystem, finding that it is an 
inherently difficult task to specify access control requirements: 
“Optimal access control specification requires an 
understanding of the nature of the task, the application systems 
that these tasks might affect, and the different access right 
configurations required to perform these tasks in the different 
configurable systems.” [10]. This problem is magnified 
manifold in a translational research scenario. Not only are there 
highly conflicting legal and policy constraints in bench- and 
bedside environments, the researchers also have conflicting 
interests (e.g. gaining access to as much data as possible vs. 
protecting patient privacy).  
Heterogeneous Access Control: The centralized approach 
of current translational research platforms does not fulfill the 
requirements of a translational research ecosystem. Current 
systems apply a single access control concept (usually RBAC 
[11]). This works well for homogenous translational research 
environments, such as the translational cancer research project 
supported by caBIG [6], since here it was deemed acceptable 
that all users register in a central system and the homogenous 
nature of the data, roles and tasks allows RBAC to be applied 
effectively. However, in a more general digital ecosystem for 
translational research, much more diverse objects, users and 
rules need to be supported. While clinical organizations often 
have central identity management frameworks and organization 
wide roles and polices (ideal for role based AC), benchside 
researchers are often organized in a more ad-hoc manner and 
can own data and autonomously decide on its use (ideal for 
discretionary AC). Thus, a digital ecosystem needs to be aware 
of and facilitate the different AC requirements of the different 
worlds and not impose a single AC paradigm on all users 
homogeneously.  
Access Control Negotiation: Another challenging aspect 
of a translational ecosystem, unique to transregional and 
transnational translational research projects, are the diverse 
legal and ethical policies governing the participating 
organizations. While traditional AC systems offer binary 
yes/no answers to access requests in a translational research 
environment, this significantly falls short of what is ideally 
required, since the diverse legal and ethical constraint create far 
more complex interaction patterns. If a benchside researcher 
from organization A in the US tries to access pseudonymized 
clinical data from organization B in Australia, a traditional AC 
system would reject the request, since sharing of clinical data 
outside of organization B is forbidden by law. However, if 
ethical approval is granted, anonymized data may be shared. 
An AC system for a translational research ecosystem needs to 
be aware of such legal constraints and be able to negotiate the 
appropriate type of access, i.e. the request should be denied 
with the added information that anonymized access can be 
permitted and ask whether the access request should be 
modified accordingly. This concept can be taken a step further, 
to offer significantly greater benefit to the researcher. In the 
above scenario, an ethical committee must be involved in the 
AC request, since even anonymized clinical data may not be 
shared by Australian organizations without permission by the 
committee on a case-by-case basis (this can takes months to 
acquire). However, clinical organizations in the federal state of 
Hamburg, Germany for instance are not as constrained. Here, a 
clinician has full personal control over data once it has been 
anonymized [12]. Thus, if similar data is present in this 
organization, gaining access to the data only requires the 
permission of a single person and thus can potentially be 
obtained in a much shorter timespan. This sort of knowledge 
about the legal and ethical constraints on the data needs to be 
incorporated into the AC system to enable optimal access to 
data in a legal and ethically compliant manner. This involves 
several aspects not currently present in AC systems, i.e. 
negotiation, reasoning and user interaction capabilities. 
Furthermore, it is desirable that the underlying infrastructure 
facilitates the organizational aspects of these processes, such as 
automatic anonymization or pseudonymization of data, 
locating relevant alternative data sources, contact persons and 
importantly the ability to offer an interactive AC process.  
Sovereign Access Control: A further consequence of the 
diverse legal and ethical laws governing the data is that it is 
unrealistic to assume that in a translational digital ecosystem 
spanning multiple countries, all data can be managed by a 
central AC system. Therefore, it is necessary to offer a 
decentralized AC system in which each participating 
organization can retain sovereign AC authority over its data. 
This is a fundamental conceptual difference to what the 
traditional infrastructure approaches offer, where the aim is to 
centralize and homogenize data storage and access as far as 
possible. 
B. Technical/Administrative  
Decentralized Control: The major infrastructure 
requirement deduced from the legal and security requirements 
is that a digital ecosystem for translational research must allow 
for decentralized regions of sovereign control. Current ICT 
infrastructures for translational research, such as [6] [7] [8], 
offer central services for a subset of tasks in translational 
research, such as user and Virtual Organization (VO) 
management, access control, data storage, as well as search and 
retrieval. While these services can be of great benefit to the 
community, the central nature of these services require 
participating organizations to adapt to the rules and capabilities 
of these systems. In a translational ecosystem, a more flexible 
decentralized approach is desirable in which participating 
organizations can retain internal organizational structures and 
procedures. In particular, the diverse structures and operational 
procedures of benchside research groups are ill suited to be 
unified into a single central management infrastructure. 
Regan et al. found that technologically there is little reason 
to avoid integration of ICT methods in e-Health ecosystems. 
Most barriers arise from acceptance and organizational issues 
with the professionals [10]. The decentralized ecosystem 
approach allows the ICT solution to be tailored more closely to 
the needs of the participating organizations.  
Human Centric Information Management: A further 
technical aspect of translational information management is 
data integration. Queries such as "Show me all pathology 
reports for Her-2/neu positive patients with a lobular 
carcinoma." or "Identify all lymphoma patients who have had 
good prognostic responses to rituximab/CHOP treatment 
regimes" are common in translational research and are 
currently often dealt with manually, i.e. the researcher queries 
the local database/software and/or requests the owner of a 
foreign data source to execute the query. Standardization 
approaches such as HL7 [13], DICOM [14] and caDSR [15] 
aim to create the basis for integrated information systems, 
which can execute queries on common data formats across 
multiple systems. Ontology based approaches are also widely 
used and allow queries across different data sources and 
domains by creating mappings between the different standards. 
While both these approaches are highly laudable and already 
offer great benefits to early adopters, standardization is still far 
from complete and ontology based approaches are very work 
intensive. Thus, many incompatibilities remain. Also, the top 
down approach (use of standard X or ontology Y mandated by 
the IT system) does not sit well with the organizational 
constraints of many medical research organizations, where the 
integration/roll-out of a new standard can be extremely labor 
intensive. In order to offer benefits to early adopters at a good 
cost to effort ratio, a translational medical ecosystem needs a 
human centric, non-invasive infrastructure to assist researchers 
in locating relevant organizations, data and fellow researchers, 
without mandating all participating organizations to adopt a 
single format and make significant changes to their current 
infrastructure.  
IV. RELATED WORK 
A. Translational Research Platforms 
Winter et al. [9] present a study on integrated information 
systems for translational research. They identify several key 
issues that such a platform needs to deal with: Availability of 
relevant items, reliable definitions of items, appropriate level of 
data quality, unambiguous identifications of objects and legally 
compliant access.  
The caTrip Project [7] is a translational research extension 
to the caBIG cancer research platform. The project’s main 
focus is on aggregating clinical and molecular data in the 
caBIG cancer research network. The platform allows users to 
pose queries such as: "What are all the ER positive patients that 
have survived breast cancer after radiation treatment?" To 
achieve this, all data must be registered with the same access 
control policies in a standardized manner in the Cancer Data 
Standards Repository using the common data elements (CDE) 
format. An RBAC AC system is set up and managed centrally 
to prevent unauthorized access to the data. Due to the 
homogeneous and centrally organized nature of the caBIG 
cancer research program, this is a legitimate approach. 
However, it is not applicable to the broader and more ad-hoc 
world of translational ecosystems. The drawback is also visible 
in the security concept proposed by caTrip, which relies on the 
Globus Toolkit Authentication Service and the Common 
Security Module (CSM) authorization. Again, due to the 
focused nature of the project and the data, the binary AC 
decision support offered by this approach is sufficient for 
caTrip. It is however not flexible enough to support a 
translational ecosystem. A competing translational research 
extension in the caBIG project is caIntegrator [6]. The 
caIntegrator project lets researchers and bioinformaticians 
access, analyze, and integrate clinical and experimental data 
across multiple clinical trials and studies. Like caTrip, the 
focus of caIntegrator is on data-integration and search. 
However, also like caTrip, the user must conform to the user 
management, data policies and a single AC system that 
enforces binary access control on the system. Neither project 
offers significant support for the ad-hoc and self-managed 
nature of many benchside projects, enforcing the same central 
administrative approach on all aspects of the research 
ecosystem. The same holds for the myGrid project [8]. 
Furthermore, the systems all focus on one specific translational 
track (e.g. cancer) and do not facilitate the collaboration of the 
different domains as is required by the scenario posed by the 
Lab for Translational Research at the Harvard Medical School 
and the Genomics Research Centre of the Griffith University. 
B. Digital Ecosystems 
Nankani et al. [16] describe universities and research 
facilities as prime examples of digital ecosystems. Research 
projects and their administration often thrive on dynamic, ad-
hoc and diverse relationships among entities and organizations. 
Fragidis et al. [17] state that research ecosystems benefit from 
clear context and support for integrated macro- and 
microscopic views. They also acknowledge the temporary 
nature of collaborations and argue that research ecosystems 
need to be relieved from excessive complexity imposed by 
project management. Furthermore, they ask for the research 
ecosystem approach to investigate "alternative or improved 
solutions in the organization and implementation of research 
activities". Both these analyses show how the digital ecosystem 
paradigm offers benefits to the dynamic research environment 
and form the solid motivation for this work.  
Katriou et al. [18] suggest support for EU research proposal 
creation via a digital ecosystem approach. The proposed 
EURPCCS system retrieves the research ecosystem’s actors via 
a set of mapping web services. The EURPCCS enables the 
suggestion of appropriate partnerships based on actor profiles. 
They demonstrate how the digital ecosystem paradigm is well 
suited to assist in the ad-hoc creation of research teams. Their 
findings strengthen the case for the benefits of digital 
ecosystem based management of translational research 
projects, since the creation of a translational research project 
shares several attributes with the creation of an EU research 
project. Their work however does not deal with the execution 
of the project, project data or security issues. Furthermore, the 
portal based solution is centrally managed, requiring all 
participating organizations to accept and adhere to the central 
policies.  
V. TRANSLATIONAL RESEARCH ECOSYSTEM 
Digital ecosystems have emerged as a new paradigm for 
complex, interdependent, loosely coupled and demand-driven 
interactive environments [19]. Traditional approaches to 
translational research information management have focused 
on how to centralize and homogenize data storage and access 
as far as possible. This runs contrary to the digital ecosystem 
paradigm and the natural usage pattern of translational 
research. In the following, we introduce Mind Mesh, a digital 
ecosystem for translational research, which presents novel 
solutions to the challenges presented in section III.  
Human Centric Information Management: Standards, 
such as HL7 [13], DICOM [14], and caDSR [15], aim to 
standardize medical data and systems to create a homogeneous 
environment in which systems can be linked and information 
can be stored and retrieved automatically. Even though much 
progress has been made, clinical information systems are still 
far from plug-and-play compatible and collaborations across 
organizational boundaries are still a complex endeavor. To 
facilitate ad-hoc collaborations across multiple domains in 
which centralized systems and standardization are not 
advanced enough yet, we introduce the concept of the Mind 
Mesh. The Mind Mesh is a conceptual extension of Mind Maps 
that allows the collaborative modeling of research 
environments. Mind Maps focus on intuitive visualization of 
ideas, reflecting the way in which humans tend to organize 
complex relationships between concepts. However the strict 
tree-structure of Mind Maps does not lend itself to modeling 
research collaborations and the relationships between the 
participating entities. The Mind Mesh models information in a 
graph structure and allows arbitrary relationships between any 
two entities. Nankani et al. [16] already showed how 
automated graph based visualization of research ecosystems is 
beneficial for human interpretation of complex research 
ecosystems. We take this concept one step further and allow 
the user to actively create and maintain the information graph 
like a Mind Map and combine the visualization with active 
components to create a fully functional visual translational 
research ecosystem. The Mind Map concept helps users find 
information in a human centric manner where automated 
search tools and central databases fail to bridge the gap 
between different translational domains. Figure 1 shows a 
partial screenshot of a Mind Mesh depicting two organizations 
A and B. Organization A is a clinical research institution and 
contains three data sets organized into two study groups and 
one project group. Each node can be annotated with keywords 
in aid of search and navigation. Unlike in a Mind Map, the 
Mind Mesh allows objects to have multiple parents, thus 
allowing data set C to be assigned both to study B as well as 
project A. This is important both for navigation and search 
reasons as well as access control reasons. Organization B, a 
basic research organization, also contains three data sets 
organized into two projects. Again, due to the graph-based 
nature, projects B and C can share data set E. Cross-
organizational data sharing is one of the major features of a 
translational research ecosystem. Four distinct data sharing 
methodologies are shown in the example: 
• Bidirectional Node to Node: Two graph nodes share their 
resources. Users of either node can access resources of 
either node, e.g. Users connected to Study B or Project B 
can access data sets B, C, D and E.  
• Unidirectional Node to Node: On graph node makes its 
resources available to another, e.g. Users of Project A can 
access data sets E and F from Project C.  
• Person to Node: A node makes its resources available to a 
person, e.g. the user assigned to Project C gains access to 
data sets D and E.  
• Person to Data: A person is granted access to a data set 
directly, e.g. the user from organization B is assigned to 
data set C from organization A.  
To grant access, a user with administrative privileges for a 
node can simply drag a connection to the new node. This 
extremely simple operation is vital to a translational research 
ecosystem, since most users do not have extensive ICT skills 
and granting correct access on the physical resources is to 
complex and requesting an administrator to execute the action 
each time is to inefficient and impractical. The technical 
execution of these graphical requests is dealt with by a plugin 
system described in the next subsection. All access is still 
constrained by organizational policies discussed in section VI. 
Decentralized Control: Particularly the legal and security 
requirements make a decentralized approach for a translational 
research ecosystem vital for its adoption. Also, user 
management and legacy system integration make a 
decentralized approach far easier to adopt. Figure 1 shows the 
architecture of the Mind Mesh ecosystem for the example 
research collaborations. Both organizations operate a Mind 
Mesh server and retain full control over their user management 
and data. The clinical research organization A uses a central 
Identity Management system to manage its users. A plugin is 
required to export the user information into the Mind Mesh 
server. The benchside organization enrolls its users directly 
with the basic inbuilt user management of the Mind Mesh 
server. Data can be stored in multiple ways (e.g. SQL database, 
HTTP, SMB, SVN servers, etc.) and each system requires a 
plugin to connect it to the Mind Mesh server. This involves an 
initial overhead, however the benefits of automated 
management at run-time are significant, since non-technical 
users can grant and revoke access to resources without 
administrative assistance. Vital components to each Mind 
Mesh server are the domain policies that are required to ensure 
legal and ethical compliance in the translational research 
environment. These will be discussed in the next section.  
 
 
Figure 1: Mind Mesh Architecture 
VI. SECURITY SYSTEM 
Using the graphical Mind Mesh paradigm introduced in 
section V, it is easy for a user in one organization to grant 
access to resources under his or her control to a user in another 
organization. However, as shown in section III, there are 
complex legal and ethical constraints that must be adhered to. 
Since dealing with these issues manually is both time 
consuming and error-prone, our digital ecosystem 
infrastructure offers several novel approaches to automate 
security and privacy relevant operations and ensure legal and 
ethical compliance. Three main issues need to be addressed: a 
security model for translational research, a policy framework 
for legal and ethical compliance and a usability concept. Each 
will be briefly sketched in the following.  
Translational Research Ecosystem Security Model: 
Reng et al. [20] did an extensive study of the different 
needs of clinical and basic research networks in medical 
research and created two distinct security model 
recommendations for each scenario. The recommendations are 
based on the German legal framework and present the two 
extremes of dealing with clinical data and are thus easily 
applicable to other legal frameworks, as we will show in the 
following. Bench side researchers potentially deal with both 
non-patient data (cell-cultures, animal samples, etc) as well as 
patient data collected mainly for research purposes. Non-
patient data does not have significant legal or ethical 
restrictions, so the procedure in Figure 2 focuses on patient 
data in benchside research. A researcher gathers clinical data 
meant primarily for research purposes with informed consent 
of the patient. The data is split into two distinct entities, the 
PID (the identifying data) and the MDAT (medical data – non 
identifying data). After a quality management step, the PID is 
pseudonymized by creating a PSN that can later be used to re-
identify the PID belonging to an MDAT. The PSN and the 
corresponding MDAT can then be made available to the 
research network online. In the following we will call this case 
R for Research data.  
 
Figure 2: Benchside Security (adapted from [20]) 
 
Patient data collected bedside, where the primary goal is patient care, 
patient care, is subject to different legal and ethical constraints.  
Figure 3 shows the setup for dealing with such patient data 
according to [20]. The physician collects the IDAT and MDAT 
from the patient with informed consent and stores the data 
locally. In case of an ethically approved request for the data, 
the anonymous MDAT can be shared offline. No one but the 
attending physician ever has access to the IDAT. In the 
following we will call this case C for clinical data.  
 
Figure 3: Bedside Security (adapted from [20]) 
  
These two approaches represent the extreme cases of data 
sharing in bench and bedside organizations and do not facilitate 
translational research. Figure 4 shows our novel unified 
security model for translational research that spans both bench 
and bedside organizations. This is the first solution that 
includes the ethical committees as a technical part of the 
security framework and the digital ecosystem as a whole. The 
two dark blue rectangles in the top left and right hand corners 
represent the two security models as recommended by [20] to 
deal with the extremes of bench and bedside data security 
needs. We add the following components to integrate the two 
worlds in a translational research ecosystem in a legally and 
ethically compliant manner. In the spirit of a minimally 
invasive approach, the existing solutions to storing and 
accessing IDAT and MDAT are left unmodified. This is done 
to reduce legal hurdles and aid acceptance. To bridge the 
translational information gap MMDAT records are created 
containing meta-data from the MDAT records. This meta-data 
includes information relevant to finding relevant data sets but 
does not contain the actual medical data (e.g. patient record 32 
of 200 in breast cancer study ages 40 to 50, VW-EPC whole 
slide image used in the Paper Mertins et al., etc.). Analogous to 
the PSN creation in case R, a pseudonymized meta-data ID 
(MIDAT) is created for each MMDAT to enable the home 
organization to link MMDAT to MDAT records. In case R the 
PSN is added to the MIDAT. In case C no personal information 
is added to the MMDAT. The MMDAT and MIDAT are then 
stored in the translational research database (TRDB) of that 
organization. The resources in the TRDB need to be shared 
with the ecosystem. While the TRDB does not contain any 
IDAT or MDAT records the information still requires access 
control protection, since not all participants in the digital 
ecosystem need to be aware of the existence of certain 
information. There can also be organizational policies that 
prevent certain users from accessing certain MMDAT records. 
 
 
Figure 4: Translational Ecosystem Security Model 
 
These issues are dealt with in more detail in the next 
subsection detailing the policy engine. Using the Mind Mesh 
interface introduced in the previous section, a user can search 
or browse MMDAT records or can be invited to access specific 
MDAT records. Once relevant data has been found, an MDAT 
or an MDAT&PSN request can be initiated, using the Mind 
Mesh interface. This is the second instance where the access 
control and policy engine is activated to check for both legal 
and ethical compliance as well as if the owner of the data 
grants access to the requester. While it is desirable that this 
process is automated as far as possible, particularly due to 
cases where the requests need to be authorized by an ethical 
committee, there still is a need for interactivity. Additionally, it 
is unrealistic to assume that owners of MDAT records will 
specify all AC rules for all possible scenarios in advance. Thus, 
even in simple cases where no committee or organizational 
policy decisions are required, an interactive AC system is 
highly desirable. In the following we will introduce our policy 
and access control design to address these needs.  
VII. POLICY AND ACCESS CONTROL FRAMEWORK 
The policy and access control framework is a vital part of 
the translational research ecosystem infrastructure. To 
summarize, the requirements identified in the previous sections 
are as follows: 
• Enable owners of data and meta-data to specify who can 
access their data in which form a-priori; 
• Enable organizations to specify who can access data and 
meta-data in which form within their domain a-priori; 
• Enable users to request access to data and meta-data; 
• Enable and automatically negotiate full, pseudonymized 
or anonymized access in cases where no policy or 
access control rule is violated; 
• Enable owners and organizations to interactively 
respond to access requests that cannot be resolved 
automatically;  
• Enable and support ethical committees to allow, reject 
or modify access requests that require ethical approval 
to comply with the legal and ethical framework. 
 
The first three requirements are addressed using the Mind 
Mesh paradigm. Connections between nodes in the graph can 
be annotated with attributes such as works_on or 
has_access_to. Based on these annotations, access control rules 
can be specified globally or for sub-graphs, e.g. anybody who 
works_on a project can access all data connected to the project. 
Similarly, a data request is as simple as dragging a connection 
between the users node and the data node. Whenever a new 
connection is added or used, the security model introduced in 
the previous section is queried to check for compliance. If the 
breach of compliance can be resolved automatically, e.g. 
pseudonymized data was requested but only anonymized data 
may be shared, automatic policy based transformation of the 
request is offered to the user. For a number of medical file 
formats (e.g. DICOM) automatic anonymizers and 
pseudonymizers exist, that allow for an automated 
transformation of the data. The plugin architecture of the 
security model allows these transformations to be executed 
during the access negotiation phase. However, not all requests 
can be dealt with automatically. This can either be due to 
particularly complex transformations (such as can occur for 
pseudonymization where re-identification is a problem) or due 
to non-reconcilable request/policy combinations (such as only 
anonymized data may be shared without ethical approval but 
pseudonymized data is required). In these cases, where the 
organizational policies or the user policies do not allow 
automated access, a user interaction event is triggered in the 
AC framework and the blocking entity is presented with the 
request. Addressing these needs requires a comprehensive but 
flexible policy engine. Especially user interaction, owner-based 
policy evaluation and data manipulation are not readily 
available in current approaches. Our work extends the Protune 
policy engine [21] to allow user interaction and policy 
negation, as is needed for the security model in the translational 
ecosystem. The following two examples show how policies 
that include interaction with a user (e.g. the ethical committee) 
are specified: 
allow(retrieve(MDAT)) :- 
isProtected(MDAT), 
userInteraction("Ethical Committee 
approval required. Approve?", MDAT), 
anonymize(MDAT). 
The above organizational policy is taken from an Australian 
Mind Mesh node. The legal and ethical requirements for the 
Australian site require that all medical data sharing must be 
approved by an ethical committee and even then only 
anonymized data may be shared. User interaction and 
anonymization are hard coded into the policy, so that no 
accidental sharing of non-anonymized or unapproved sharing 
can take place. In the case of a German site the policy options 
are more flexible: 
allow(retrieve(MDAT)) :- 
isPublic(MDAT), 
anonymize(MDAT). 
allow(retrieve(MDAT)) :- 
isPublic(MDAT), 
isProjectPartner(MDAT, $Requester), 
allow(retrieve(MDAT)) :- 
isProtected(MDAT), 
userInteraction("User $Requester 
requests:", MDAT), 
In this case, anyone can access to data if the owner of the 
data ensures that the data is anonymized and marks it as public. 
If the data is marked as protected, only project partners may 
access it. Any other access attempts will trigger a user 
interaction informing the owner of the data about the request 
and the requester. A rule definition including constructs to 
address these concerns directly instead of using external 
mechanisms enables concise and flexible specifications. The 
semantic information contained in the Mind Mesh graph allows 
these policies to be specified visually, queried and also 
visualized, which is of great benefit to the non-technical users 
of our translational research ecosystem. 
 
 
 
Figure 5 shows two screenshots of two policy queries, 
based on the project graph in Figure 1. The first query was 
executed by the owner of F to find out who as access to the 
resource. Since user B belongs to another organization and is 
Figure 5: Access Control Visualization 
unknown to the owner, the second query shows over which 
policy path user B has access to the resource. This visualization 
of access rights is a significant aid, especially for non-technical 
users in complex digital ecosystems. 
VIII. TECHNOLOGY 
The infrastructure prototype underlying our translational 
research ecosystem is based on several components. The novel 
Mind Mesh servers are built on top of the Openfire XMPP 
implementation. XMPP provides secure real-time server-to-
server and server-to-client communication and offers a robust 
and highly extensible basis for the ecosystem. We currently 
support X.509, LDAP and/or self managed username/password 
authentication. Additional IDM and authentication systems can 
easily be integrated via a standard security layer. The Mind 
Mesh graph itself is stored as Resource Description Framework 
(RDF) triples, since graph relationships between nodes directly 
correspond to the subject – predicate – object paradigm of 
RDF. This also has the benefit that we can use SPARQL to 
query the graph for search operations. We extended the Protune 
policy and negotiation engine for our access control negation 
framework. We currently implemented two security plugins, 
one allows rules to be defined in the Mind Mesh UI and 
translated into SQL database access control rules and the other 
allows the automated anonymization of DICOM records. The 
Mind Mesh UI is browser based since this significantly reduces 
the deployment and management effort and facilitates adoption 
of the digital ecosystem paradigm in the medical environment. 
IX. CONCLUSION AND FUTURE WORK 
In this paper, we introduced a novel digital ecosystem 
design and infrastructure for transnational, translational 
medical research. Several key contributions were made – we 
identified why traditional IT infrastructures approaches fall 
short of fulfilling the needs of translational researchers and 
deduced the key issues for our digital ecosystem based 
approach. We presented a novel XMPP based decentralized 
support infrastructure for the management of translational 
research ecosystems. A new security model encompassing the 
different security requirements of bench and bedside research 
environments was designed and implemented with several 
proof of concept plug-ins to automate security related 
operations, reducing the manual effort of legal and ethically 
compliant collaboration. The security design allows each 
participant in the digital ecosystem to retain control over their 
data and specify custom policies to ensure legal and ethical 
compliance in this complex environment.  
There are several areas for future work. Currently, the 
entire research ecosystem is visualized completely with all 
details. As the networks grow it will become necessary to 
reduce the amount of information shown at any given time. For 
this, novel approaches to select relevant information are needed 
as well as the capability to define and select views within the 
ecosystem. While the AC rules can already be defined 
graphically within the ecosystem UI, the Protune policy rules 
must still be defined manually which requires some technical 
expertise. Here, an integration of the Protune Attempto 
Controlled English policy definition UI into the Mind Mesh UI 
would significantly ease the creation and management of 
policies. An extensive user study is scheduled for the public 
beta later this year.   
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